While Quest Diagnostics raised its revenue and adjusted earnings guidance for full-year 2025, the company lowered its GAAP ...

Fintel reports that on October 22, 2025, Truist Securities maintained coverage of Quest Diagnostics (NYSE:DGX) with a Hold ...

Fintel reports that on October 22, 2025, Barclays maintained coverage of Quest Diagnostics (NYSE:DGX) with a Equal-Weight ...

At the molecular level, transcriptomic profiling of a single nucleus RNA-seq dataset of renal epithelial cells revealed ...

Medical diagnostics firm Hologic is set to change hands. Private equity firms Blackstone and TPG announced on Tuesday that ...

Researchers identify FGFR4, FLT1, and WNT5A as key biomarkers and suggest dovitinib and nintedanib as new targeted therapies ...

York-headquartered diagnostic test manufacturer Abingdon Health has announced a fundraise of about £3.5m to support its US expansion.

The NHS has also set a target for 85% of people with a cancer diagnosis to have their first treatment within two months of ...

Using spare capacity in the private sector is key to the government’s target of ensuring that 92 per cent of patients in ...

The Irish Cancer Society has said there is a complacent notion that Ireland is doing well in terms of cancer treatment.

Benchmark anticipates that Abbott’s Diagnostics business will pick up speed again in 2026 with the introduction of a new ...